Literature DB >> 19584579

A 15-year-old girl with pancytopenia and congenital defects.

Ahmed M AlSuliman1, Kafiah Al Qadaiub.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19584579      PMCID: PMC2841463          DOI: 10.4103/0256-4947.55315

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


× No keyword cloud information.
A 15-year-old girl was referred to our hospital because of lethargy, palpitation and headache. Physical examination revealed a girl with short stature, café-au-lait spots, and left thumb abnormality. The hematologic parameters of the patient included hemoglobin 5.5 g/dL, WBC 2.96×109/L, platelets 38×109/L, and mean corpuscular volume 100 fL. Radiologic examination of the hands and abdomen revealed abnormal findings that gave a clue to the diagnosis. What is the abnormal finding on this plain radiograph of the hands (Figure 1)?
Figure 1

Plain radiograph of the hands.

Plain radiograph of the hands. What are the abnormal findings on this abdominal CT scan (Figure 2)?
Figure 2

Abdominal CT scan.

Abdominal CT scan. What's your diagnosis? FOR THE ANSWER, VISIT: http://www.saudiannals.net

Diagnosis: Fanconi anemia

The abnormal finding in Figure 1 is the absence of the left thumb. In Figure 2, the abnormal findings are the absence of the left kidney and compensatory hypertrophic large right kidney. The diagn nosis is Fanconi anemia with short stature, café-au-lait spot, pancytopenia, absence of the left thumb, and absence of the left kidney.

DISCUSSION

Fanconi anemia (FA) is an autosomal recessive disease, characterized by congenital abnormalities,1 in addition to defective hematopoiesis, and a high risk of developing acute myeloid leukemia and certain solid tumors.23 Congenital abnormalities include skin pigmentation and/or café au lait spots, short stature, malformation of the skeleton (microcephaly, spina bifida, scoliosis, absent radii or thumbs). Congenital malformations of the thumbs are variable and often bilateral.4 Abnormal male gonads formation, head, eyes, ear, genitourinary, gastrointestinal tract, cardiopulmonary, central nervous system can occur.15–7 The most important clinical features of Fanconi anemia are hematological. Fanconi anemia is the commonest type of inherited bone marrow failure syndrome and the incidences of aplastic anemia, myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML).89 Cells from Fanconi anemia patients show an abnormally high frequency of spontaneous chromosomal breakage and the diagnostic test is elevated breakage after incubation of peripheral blood lymphocytes with DNA cross-linking diepoxybutane (DEB test).1011 Allogeneic stem cell transplantation from an HLA-matched sibling donor is the only curative therapy, and mild conditioning regimes are used because of the sensitivity of patient's cell to DNA damage.1213
  12 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

2.  Clonal monosomy 7 in a megakaryoblastic leukemia developed on the basis of Fanconi anemia.

Authors:  Zerrin Yilmaz; Bülent Alioğlu; Ozge Ozalp; Başak Taburoğlu Yilmaz; Hatice Emel Ozyürek; Namik Ozbek; Feride Iffet Sahin
Journal:  J Pediatr Hematol Oncol       Date:  2005-10       Impact factor: 1.289

Review 3.  Genetic basis of Fanconi anemia.

Authors:  Grover C Bagby
Journal:  Curr Opin Hematol       Date:  2003-01       Impact factor: 3.284

4.  Otologic manifestations of Fanconi anemia.

Authors:  Felipe Santos; Samuel H Selesnick; Robert A Glasgold
Journal:  Otol Neurotol       Date:  2002-11       Impact factor: 2.311

5.  A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network.

Authors:  José Antonio Casado; Elsa Callén; Ariana Jacome; Paula Río; Maria Castella; Stephan Lobitz; Teresa Ferro; Arturo Muñoz; Julián Sevilla; Angeles Cantalejo; Elena Cela; José Cervera; Jesús Sánchez-Calero; Isabel Badell; Jesús Estella; Angeles Dasí; Teresa Olivé; Juan José Ortega; Antonia Rodriguez-Villa; María Tapia; Antonio Molinés; Luis Madero; José C Segovia; Kornelia Neveling; Reinhard Kalb; Detlev Schindler; Helmut Hanenberg; Jordi Surrallés; Juan A Bueren
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

6.  Fanconi anemia patient with bilaterally hypoplastic scapula and unilateral winging associated with scoliosis and rib abnormality.

Authors:  Sule Unal; Fatma Gumruk
Journal:  J Pediatr Hematol Oncol       Date:  2006-09       Impact factor: 1.289

7.  Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia.

Authors:  J Zanis-Neto; M E D Flowers; C R Medeiros; M A Bitencourt; C M Bonfim; D C Setúbal; V Funke; J Sanders; H J Deeg; H P Kiem; P Martin; W Leisenring; R Storb; R Pasquini
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

8.  Cytogenetic investigation in Iranian patients suspected with Fanconi anemia.

Authors:  Sameeramis Tootian; Frouzandeh Mahjoubi; Mitra Rahnama; Fabyola Hormozian; Farzaneh Mortezapour; Faegeh Razazian; Farnoosh Manoochehri; Mahsa Zamanian; Fatemeh Nasiri; Saeedeh Soleymani; Ladan Seyedmortaz
Journal:  J Pediatr Hematol Oncol       Date:  2006-12       Impact factor: 1.289

9.  Endocrine abnormalities in patients with Fanconi anemia.

Authors:  Neelam Giri; Dalia L Batista; Blanche P Alter; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958

10.  Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

Authors:  Hester J T van Zeeburg; Peter J F Snijders; Thijs Wu; Eliane Gluckman; Jean Soulier; Jordi Surralles; Maria Castella; Jacqueline E van der Wal; Johan Wennerberg; Joseph Califano; Eunike Velleuer; Ralf Dietrich; Wolfram Ebell; Elisabeth Bloemena; Hans Joenje; C René Leemans; Ruud H Brakenhoff
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.